NEW YORK (GenomeWeb) – Hibergene said last week that it has received CE marking for its HG Meningococcus Direct CSF test and launched it.

The test leverages loop mediated isothermal amplification technology and enables the rapid detection of Neisseria meningitidis, a leading cause of bacterial meningitis, directly from cerebrospinal fluid samples in less than 50 minutes. It can detect all known Neisseria meningitidis serogroups, including A, B, C, 29E, W135, X, Y, and Z at low levels with high accuracy, the Dublin-based firm said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.